Probing the release of the chronobiotic hormone melatonin from hybrid calcium alginate hydrogel beads
By:
References
- 1. S. M. Reppert, D. R. Weaver and C. Godson, Melatonin receptors step into the light: cloning and classification of subtypes, Trends Pharmacol. Sci.17 (1996) 100–102; https://doi.org/10.1016/0165-6147(96)10005-510.1016/0165-6147(96)10005-5
- 2. E. Mills, P. Wu, D. Seely and G. Guyatt, Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis, J. Pineal. Res.39 (2005) 360–366; https://doi.org/10.1111/j.1600-079X.2005.00258.x10.1111/j.1600-079X.2005.00258.x16207291
- 3. S. Malhotra, G. Sawhney and P. Pandhi, The therapeutic potential of melatonin: a review of the science, MedGenMed.6 (2004) 46; https://doi.org/10.0000/ncbi.nlm.nih.gov/PMC1395802
- 4. M. L. Dubocovich, P. Delagrange, D. N. Krause, D. Sugden, D. P. Cardinali and J. Olcese, International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein coupled melatonin receptors, Pharmacol. Rev.62 (2010) 343–380; https://doi.org/10.1124/pr.110.00283210.1124/pr.110.002832296490120605968
- 5. L. M. Hack, S. W. Lockley, J. Arendt and D. J. Skene, The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects, J. Biol. Rhythms.18 (2003) 420–429; https://doi.org/10.1177/074873040325679610.1177/074873040325679614582858
- 6. A. J. Lewy, J. N. Rough, J. B. Songer, N. Mishra, K. Yuhas and J. S. Emens, The phase shift hypothesis for the circadian component of winter depression, Dialogues Clin. Neurosci.9 (2007) 291–300.10.31887/DCNS.2007.9.3/alewy
- 7. J. Arendt and D. J. Skene, Melatonin as a chronobiotic, Sleep Med. Rev.9 (2005) 25–39; https://doi.org/10.1016/j.smrv.2004.05.00210.1016/j.smrv.2004.05.00215649736
- 8. R. Sharma, C. R. McMillan, C. C. Ten and L. P. Niles, Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson’s disease, Brain Res.1068 (2006) 230–236; https://doi.org/10.1016/j.brainres.2005.10.08410.1016/j.brainres.2005.10.08416375867
- 9. M. Olcese, C. Cao, T. Mori, M. B. Mamcarz, A. Maxwell, M. J. Runfelt, C. Wang, X. Lin, G. Zhang and G. W. Arendash, Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease, J. Pineal Res.47 (2009) 82–96; https://doi.org/10.1111/j.1600-079X.2009.00692.x10.1111/j.1600-079X.2009.00692.x19538338
- 10. S. G. Grant, M. A. Melan, J. J. Latimer and P. A. Witt-Enderby, Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives, Expert Rev. Mol. Med.11 (2009) e5. https://doi.org/10.1017/S146239940900098210.1017/S1462399409000982430173519193248
- 11. S. Sibel, Melatonin and synthetic analogs as antioxidants, Curr. Drug Deliv. 10 (2013) 71–75; https://doi.org/10.2174/156720181131001001310.2174/156720181131001001322998047
- 12. M. Vlachou and A. Siamidi, Melatonin Modified Release Formulations, in Melatonin – Molecular Biology, Clinical and Pharmaceutical Approaches (Ed. C. M. Dragoi); http://dx.doi.org/10.5772/intechopen.7833710.5772/intechopen.78337
- 13. M. Vlachou, A. Siamidi, I. Pareli, A. Zampakola and S. Konstantinidou, An account of modified release of melatonin from compression-coated, uncoated and bilayer tablets, J. Pharm. Pharm. Scien.1 (2016) 10–14; https://doi.org/10.24218/vjpps.2016.1910.24218/vjpps.2016.19
- 14. M. Vlachou, A. Siamidi, S. Konstantinidou and Y. Dotsikas, Optimization of controlled release matrix formulation of melatonin via experimental design, J. Pharm. Drug Deliv. Res.5 (2016) 1–5; https://doi.org/10.4172/2325-9604.100015910.4172/2325-9604.1000159
- 15. A. Zampakola, A. Siamidi, N. Pippa, C. Demetzos and M. Vlachou, Chronobiotic hormone melatonin: comparative in vitro release studies from matrix tablets and liposomal formulations, Lett. Drug Des. Discov.14 (2017) 476–480; https://doi.org/10.2174/157018081366616100616224610.2174/1570180813666161006162246
- 16. M. Vlachou, M. Papamichael, A. Siamidi, I. Fragouli, P. A. Afroudakis, R. Kompogennitaki and Y. Dotsikas, Comparative in vitro controlled release studies on the chronobiotic hormone melatonin from cyclodextrins-containing matrices and cyclodextrin: melatonin complexes, Int. J. Mol. Sci.18 (2017) 1641; https://doi.org/10.3390/ijms1808164110.3390/ijms18081641557803128788064
- 17. M. Vlachou, K. Tragou, A. Siamidi, S. Kikionis, A. L. Chatzianagnostou, A. Mitsopoulos, E. Ioannou, V. Roussis and A. Tsotinis, Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan, J. Drug Deliv. Sci. Technol.44 (2018) 41–48; https://doi.org/10.1016/j.jddst.2017.11.01910.1016/j.jddst.2017.11.019
- 18. M. Vlachou, S. Kikionis, A. Siamidi, K. Tragou, E. Ioannou, V. Roussis and A. Tsotinis, Modified in vitro release of melatonin loaded in nanofibrous electrospun mats incorporated into mono-layered and three-layered tablets, J. Pharm. Sci.108 (2019) 970–976; https://doi.org/10.1016/j.xphs.2018.09.03510.1016/j.xphs.2018.09.03530312723
- 19. M. Vlachou, S. Kikionis, A. Siamidi, K. Tragou, S. Kapoti, E. Ioannou, V. Roussis and A. Tsotinis, Fabrication and characterization of electrospun nanofibers for the modified release of the chronobiotic hormone melatonin, Curr. Drug Deliv. 16 (2019) 79–85; https://doi.org/10.2174/156720181566618091409570110.2174/1567201815666180914095701634015330215335
- 20. M. Vlachou, G. Stavrou, A. Siamidi, S. Flitouri, V. Ioannidou and S. Mavrokordopoulos, N-Acetylserotonin vs. melatonin. In vitro controlled release from hydrophilic matrix tablets, Lett. Drug Des. Discov.16 (2019) 347–352; https://doi.org/10.2174/157018081566618040412551910.2174/1570180815666180404125519
- 21. B. Girgin, O. Korkmaz, R. Yavaşer and A. A. Karagözler, Production and drug release assessment of melatonin-loaded alginate/gum arabic beads, JOTCSA3 (2016) 205–216; https://doi.org/10.18596/jotcsa.3088010.18596/jotcsa.30880
- 22. O. Şanlı, N. Ay and N. Işıklan, Release characteristics of diclofenac sodium from poly (vinyl alcohol)/sodium alginate and poly (vinyl alcohol)-grafted-poly (acrylamide)/sodium alginate blend beads, Eur. J. Pharm. Biopharm.65 (2007) 204–214; https://doi.org/10.1016/j.ejpb.2006.08.00410.1016/j.ejpb.2006.08.004
- 23. N. Pippa, N. Bouropoulos, S. Pispas, C. Demetzos and A. Papalois, Chapter 3. Hydrogels as intelligent drug delivery systems in drug delivery, Nanosystems 2019; 59–91; https://doi.org/10.1201/9780429490545-310.1201/9780429490545-3
- 24. Pharmacopeia US, USP 29-NF24, Rockville, 2005.
- 25. G. Pasparakis and N. Bouropoulos, Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads, Int. J. Pharm.323 (2006) 34–42; https://doi.org/10.1016/j.ijpharm.2006.05.05410.1016/j.ijpharm.2006.05.054
- 26. I. Colinet, V. Dulong, G. Mocanu, L. Picton and D. Le Cerf, New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug, Eur. J. Pharm. Biopharm.73 (2009) 345–350; https://doi.org/10.1016/j.ejpb.2009.07.00810.1016/j.ejpb.2009.07.008
- 27. N. Pippa, T. Sentoukas, S. Pispas, C. Demetzos, A. Papalois and N. Bouropoulos, pH-responsive polymeric nanoassemblies encapsulated into alginate beads: morphological characterization and swelling studies, J. Pol. Res.25 (2018) 117; https://doi.org/10.1007/s10965-018-1519-110.1007/s10965-018-1519-1
- 28. J. Siepmann and N. A. Peppas, Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC), Adv. Drug Deliv. Rev.48 (2001) 139–57; https://doi.org/10.1016/S0169-409X(01)00112-010.1016/S0169-409X(01)00112-0
- 29. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release II. Fickian and anomalous release from swellable devices, J. Control. Release5 (1987) 37–42; https://doi.org/10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6
- 30. Ν. Η. Anderson, Μ. Bauer, Ν. Boussac, Ρ. R. Khan-Malek, P. Munden and M. Sardaro, An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles, J. Pharm. Biomed. Anal. 17 (1998) 811–822; https://doi.org/10.1016/s0731-7085(98)00011-910.1016/S0731-7085(98)00011-9
- 31. J. L. Shamshina, G. Gurau, L. E. Block, L. K. Hansen, C. Dingee, A. Walters and R. D. Rogers, Chitin--calcium alginate composite fibers for wound care dressings spun from ionic liquid solution, J. Mater. Chem. B2 (2014) 3924; http://dx.doi.org/10.1039/C4TB00329B10.1039/C4TB00329B
- 32. S. Soni, A. Verma and V. Ram, Evaluation of chitosan-hydroxy propyl methyl cellulose as a single unit hydrodynamically balanced sustained release matrices for stomach specific delivery of piroxicam, MOJ Bioequiv. 2 (2016) 14; http://dx.doi.org/10.4172/0975-0851.C1.02510.4172/0975-0851.C1.025
- 33. T. H. C. Salles, C. B. Lombello and M. A. d’ Ávila, Electrospinning of gelatin/poly (vinyl pyrrolidone) blends from water/acetic acid solutions, Materials Research18 (2015) 509–518; http://dx.doi.org/10.1590/1516-1439.31011410.1590/1516-1439.310114
- 34. Y. Listiohadi, J. A. Hourigan, R. W. Sleigh and R. J. Steele, Thermal analysis of amorphous lactose and α-lactose monohydrate, Dairy Sci. Technol.89 (2009) 43–67; https://doi.org/10.1051/dst:200802710.1051/dst:2008027
- 35. A. S. Hoffman Hydrogels for biomedical applications, Adv. Drug Deliv. Rev.43 (2002) 3–12; https://doi.org/10.1016/j.addr.2012.09.01010.1016/j.addr.2012.09.010
- 36. S. P. Chaudhari and R. H. Dave, Investigating the effect of molecular weight of polyvinylpyrrolidone and hydroxypropyl methyl cellulose as potential antiprecipitants on supersaturated drug solutions and formulations using weakly acidic drug: indomethacin, IJPSR7 (2016) 3931–3948; https://doi.org/10.13040/IJPSR.0975-8232.7(10).3931-4810.13040/IJPSR.0975-8232.7(10).3931-48
- 37. A. Körner, L. Piculell, F. Iselau, B. Wittgren and A. Larsson, Influence of different polymer types on the overall release mechanism in hydrophilic matrix tablets, Molecules14 (2009) 2699–2716; https://doi.org/10.3390/molecules1408269910.3390/molecules14082699625537619701117
- 38. M. Vlachou, A. Siamidi and E. Geraniou, Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets, Acta Pharm.70 (2020) 49–61; https://doi.org/10.2478/acph-2020-001010.2478/acph-2020-001031677367
Language: English
Page range: 527 - 538
Accepted on: Dec 17, 2019
Published on: May 13, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 Marilena Vlachou, Angeliki Siamidi, Efstratia Goula, Panagiotis Georgas, Natassa Pippa, Vangelis Karalis, Theodore Sentoukas, Stergios Pispas, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.